Upload
others
View
0
Download
0
Embed Size (px)
Citation preview
r r
INDEPENDENT RESEARCH UPDATE Unilever
31st March 2017 Cautiousness first
Food & Beverages Fair Value EUR44 (price EUR46.80) NEUTRAL
Bloomberg UNA NA
Reuters UNc.AS
12-month High / Low (EUR) 46.8 / 36.4
Market capitalisation (EURm) 117,894
Enterprise Value (BG estimates EURm) 128,314
Avg. 6m daily volume ('000 shares) 4 476
Free Float 100%
3y EPS CAGR 9.4%
Dividend yield (12/17e) 2.95%
UK takeover rules mean Kraft Heinz is blocked from making another
bid for Unilever for six months after withdrawing its initial attempt. The
most important question is: will the US company return at the end of this
period? We do not think so. The fact that the bid was rejected with such
ease suggests that Kraft-Heinz made a hasty decision. But this does not
mean Unilever is not in play mode. Unilever’s share price is now 18%
above the pre-offer level, which means the group is under pressure to
meet investor expectations. The group is conducting a review, the results
of which will be announced at the beginning of April.
We think the company will choose the most cautious options, which are
increasing returns to shareholders (buybacks) and cost savings. Why?
Two reasons: 1/ there is no need for Unilever to change its entire
strategy simply because Kraft-Heinz made an attempt and 2/ Unilever is
not an underperformer with a TSR of 194% over the past eight years vs
137% for the Stoxx Europe 600. The ideas of splitting food and HPC,
disposing of the entire food business or undertaking wide-scale M&A
seem overly aggressive to us. However, we are not ruling out the
prospect of the group deciding to sell its BCS unit, probably as part of a
buyback programme.
If we are right, this would increase our FV from EUR44 to EUR49.5,
implying upside potential of only 6%. This means the positive news we
expect the group to announce is already partly factored into the share
price while any disappointment could have a very detrimental impact for
the performance, especially since Q1 2017 should be very soft. Like its
peers, Unilever is expected to be impacted by the leap year and the late
timing of Easter. This should have a negative technical effect of -100bps
and -50bps. The slowdown in Brazil, the demonetisation in India,
political uncertainty and delays in tax returns in the US should also be
penalising. Our estimate is for 1% organic sales growth in Q1 vs +3.5%
in 2017.
YE December 12/16 12/17e 12/18e 12/19e
Revenue (EURm) 52,713 55,580 57,884 60,657
EBIT (EURm) 8,046 8,929 9,568 10,317
Basic EPS (EUR) 1.89 2.10 2.27 2.47
Diluted EPS (EUR) 1.88 2.09 2.26 2.46
P/E 24.9x 22.4x 20.7x 19.0x
ROCE 17.9 19.0 20.5 22.1
29.7
31.7
33.7
35.7
37.7
39.7
41.7
43.7
45.7
47.7
30/09/15 31/12/15 31/03/16 30/06/16 30/09/16 31/12/16
UNILEVER DR SXX EUROPE 600
Analyst: Sector Analyst Team:
Virginie Roumage Nikolaas Faes
33(0) 1.56.68.75.22 Loïc Morvan
[email protected] Antoine Parison
Cédric Rossi
Unilever
2
Simplified Profit & Loss Account (EURm) 2014 2015 2016 2017e 2018e 2019e
Revenues 48,436 53,272 52,713 55,580 57,884 60,657
Reported change (%) -2.7% 10.0% -1.0% 5.4% 4.1% 4.8%
Organic change (%) 2.9% 4.1% 3.7% 3.5% 4.1% 4.8%
Adjusted EBITDA 8,147 9,235 9,417 10,374 11,073 11,894
EBIT 7,020 7,865 8,046 8,929 9,568 10,317
Change (%) 0.1% 12.0% 2.3% 11.0% 7.2% 7.8%
Financial results (477) (493) (563) (530) (495) (460)
Profits from associates 143 198 231 188 195 202
Pre-Tax profits 7,646 7,220 7,469 8,587 9,268 10,059
Tax (2,131) (1,961) (1,922) (2,220) (2,397) (2,602)
Minority interests 344 350 363 400 420 434
Net profit _ group share 5,171 4,909 5,184 5,967 6,452 7,023
Restated net profit 4,634 5,210 5,370 5,967 6,452 7,023
Change (%) 0.6% 12.4% 3.1% 11.1% 8.1% 8.9%
Cash Flow Statement (EURm)
Operating cash flows 7,854 9,351 9,298 10,424 11,034 11,845
Change in working capital 8.0 720 51.0 114 24.9 14.3
Capex, net (2,045) (2,074) (1,878) (1,945) (2,026) (2,123)
Financial investments, net (398) (460) (367) (400) (400) (399)
Dividends (3,189) (3,331) (3,609) (3,656) (3,949) (4,264)
Other (1,444) (1,605) (61,109) 0.0 0.0 0.0
Net debt (9,900) (11,505) (12,614) (10,420) (8,045) (5,466)
Free Cash flow 3,100 4,796 4,802 5,859 6,212 6,720
Balance Sheet (EURm)
Tangible fixed assets 10,472 11,058 11,673 10,636 9,504 8,259
Intangibles assets 22,174 25,059 27,433 28,530 29,672 30,858
Cash & equivalents 2,151 2,302 3,382 1,135 3,025 4,342
current assets 10,196 10,384 10,502 11,321 11,947 12,770
Other assets 3,034 3,495 3,439 3,577 3,720 3,868
Total assets 48,027 52,298 56,429 55,199 57,868 60,098
L & ST Debt 12,722 14,643 16,595 12,335 11,968 10,835
Others liabilities 21,042 21,573 22,854 23,567 24,093 24,692
Shareholders' funds 13,651 15,439 16,354 18,665 21,168 23,927
Total Liabilities 33,764 36,216 39,449 35,902 36,061 35,526
Capital employed 29,237 31,468 34,615 34,562 34,545 34,474
Ratios
Operating margin 14.49 14.76 15.26 16.06 16.53 17.01
Tax rate (28.23) (27.57) (26.20) (26.27) (26.27) (26.27)
Net margin (restated) 9.57 9.78 10.19 10.74 11.15 11.58
ROIC 18.36 18.87 17.90 19.05 20.49 22.12
Pay out ratio 69.67 66.21 68.05 66.13 66.06 65.54
Number of shares, diluted 2,883 2,855 2,854 2,855 2,855 2,855
Data per Share (EUR)
Restated basic EPS 1.63 1.83 1.89 2.10 2.27 2.47
Restated diluted EPS 1.61 1.82 1.88 2.09 2.26 2.46
% change 2.0% 13.5% 3.1% 11.1% 8.1% 8.9%
BVPS 4.74 5.41 5.73 6.54 7.41 8.38
Operating cash flows 2.72 3.27 3.26 3.65 3.86 4.15
FCF 1.08 1.68 1.68 2.05 2.18 2.35
Net dividend 1.12 1.21 1.28 1.38 1.49 1.61
Source: Company Data; Bryan, Garnier & Co ests.
Company description
Unilever is an Anglo-Dutch company
present in four product categories
(Foods, Refreshments, Personal Care
and Home Care) and divided into
three regions (Asia/AMET/RUB,
Americas, Europe).
Personal care38%
Foods24%
Resfreshment19%
Home Care19%
Sales breakdown by category, 2016
Asia/AMET/RUB43%
The Americas
33%
Europe24%
Sales breakdown by geography, 2016
Unilever
3
1. Genesis
On February 17th, Kraft-Heinz and Unilever confirmed the approach after FT Alphaville reporters,
in their Markets Live chat, discussed market rumours of a potential Kraft-Heinz bid for Unilever. The
proposal received was USD50 per share, with three-fifths payable in cash and two-fifths in shares.
This would have valued Unilever at a total equity of around USD143bn and represented a premium of
18% to the pre-offer share price. Within the food/HPC industry, acquisitions are usually carried out
at a 35% premium and it is reasonable to think that the acquisition of Unilever would not have been
an exception.
Fig. 1: Transactions in food/HPC in the last 10 years
Date Buyer Target % premium
2017 Reckitt-Benckiser Mead Johnson 30%
2016 Danone WhiteWave 19%
2015 Acorn holdings Keurig Green Mountain 78%
2015 Kraft Heinz Kraft Food 27%
2013 Henan Luohe Shuanghui Smithfield Foods 31%
2013 JAB Holdings D.E Master Blenders 1753 33%
2013 Berskshire Hathaway / 3G Capital Kraft Heinz 20%
2009 Kraft Cadbury 48%
2008 Mars Wrigley 28%
2007 Danone Numico 38%
Average 35%
Source: Companies, Bryan, Garnier & Co
Kraft Heinz, which is 27%-owned by Berkshire Hathaway and 24%-owned by 3G, has always had the
profile of a predator. So it was hardly surprising that the group was interested in Unilever's food
portfolio, which is one of the most largest in the world and has a global exposure. What was far more
unexpected was that the US company bid for the whole of Unilever. We do not think that its plan was
to dispose of the HPC business as this is the group's growth driver and leads EBIT margin
improvement.
The proposal was fiercely declined by Unilever, which said it lacked financial and strategic merits and
the price fundamentally undervalued the company. In contrast, Kraft seemed determined to pursue
the negotiations. In accordance with the UK Code on Takeovers and Mergers, Kraft had one month
to announce its firm intention or not to make an offer for Unilever.
However, it finally announced it had withdrawn its bid for Unilever only two days after the news
became public…a surprising move given that Kraft-Heinz appears as to be the most fearless
consolidator in the industry. We think the combination of political opposition and Unilever’s
resistance explain this move:
Unilever
4
The response from the political classes in the UK and Netherlands was very hostile. UK
politicians were concerned about another big UK company being acquired by a foreign
group following Brexit. Kraft Foods’ 2010 takeover of UK chocolate-maker Cadbury, in
which the acquirer later reneged on promises to retain factories in Britain, traumatised a vast
majority of UK politicians. The Dutch authorities were much quieter but legally able to
block a bid that threatens jobs or jeopardises the country’s national interests. The
parliamentary elections in the country were scheduled a month later, on 15th March.
Unilever's board and management proved to be highly resistant to the bid due to the cultural
divide between the two companies. Unilever CEO Mr Polman has always encouraged long-
term investors and preached the need to balance long-term sustainability with profitability.
The priority of 3G/Kraft is to cut costs and extend trade payables. 3G should have realised
that Unilever's management and board would never fully embrace its philosophy and the bid
would have been rejected even if the premium to the undisturbed share price were increased
from 18% to 40%. A 40% premium is equivalent to three years of total shareholder returns
(14% on average per year over the past eight years since Mr Polman became CEO). If
Unilever had agreed to the offer, it would have accelerated three years of TSR into one year
but would have lost a century of heritage and its culture would have been dismantled.
Unilever now has to prove it can generate the value it overlooked.
As time went by, it became apparent that Kraft-Heinz would have to go hostile - a process that would
have been expensive, time-consuming and potentially fruitless due to political opposition. This is why
the company preferred to walk away. We can also highlight Mr Buffett’s reluctance for hostile
takeovers. In his 2015 letter to shareholders, he said “At Berkshire, we only go where we are
welcome”.
Unilever
5
2. Is Unilever in play mode?
UK takeover rules mean Kraft Heinz is blocked from making another bid for Unilever for six months
after withdrawing its initial attempt. The most important question is: will the US company return at
the end of the period? We do not think so. The fact that the bid was rejected with such ease suggests
that Kraft-Heinz took a hasty decision. But this does not mean Unilever is not in play mode.
Unilever’s share price is now 18% above the pre-offer level, which means the group is under pressure
to meet investors’ expectations.
In a statement delivered on 22nd February, Unilever issued a press release stating it is now targeting
EBIT margin improvement in 2017 of 80bps vs 40bps previously. This is at the upper end of the
group’s medium-term guidance which was revised upwards from 20-40bps to 40-80bps at the investor
seminar at the end of November. At that time, we revised upwards our 2017 EBIT margin from
15.7% to 16.1%. The group’s announcement was a way of conceding that the percentage of savings
that fall to the bottom line needed to be increased after Kraft-Heinz’s unsuccessful bid. These savings
should amount to at least EUR1bn by 2018 and should be generated across both brand and marketing
investments and overheads thanks to the implementation of organisational/pricing changes and ZBB.
On 22nd February, the Anglo-Dutch company also announced it is conducting a comprehensive
review of options to improve value for shareholders. The results will be provided in early April.
We think the company will choose the most cautious options, which are increasing returns to
shareholders (buyback) and cost savings. Why? Two reasons: 1/ there is no need for Unilever to
change its entire strategy simply just because Kraft-Heinz made an attempt and 2/ Unilever is not an
underperformer with a TSR of 194% over the past eight years vs 137% for the Stoxx Europe 600.
The ideas of splitting food and HPC, disposing of the entire food business or undertaking wide-scale
M&A seem overly aggressive to us. However, we are not ruling out the prospect of the group
deciding to sell its spreads business in developed countries.
CEO Paul Polman seems to be seeking some political protection but cannot afford to only count on
this. He has urged the UK government to provide more help for a national company that is targeted
by a foreign bidder. For example, the target could legally have more time to build a defence against
the offer and directors could be encouraged to consider the interests of all stakeholders, including
employees, rather than just shareholders. At present, takeovers can only be blocked in the UK on the
basis of national security, financial stability and media plurality.
Unilever
6
3. Accelerating margin expansion
Despite a solid share price performance, Unilever’s EBIT margins do not compare very favourably to
many of its European peers. This is mainly due to the home care and refreshment businesses.
Fig. 2: EBIT margin of Unilever vs peers, 2016
Source: Companies, Bryan, Garnier & Co
The value creation of a Kraft-Heinz bid for Unilever was due to come from the cost savings that
would have been generated by applying the culture of Kraft-Heinz to the Anglo-Dutch company. We
assume the synergies would not have exceeded 7% of Unilever’s sales due to limited geographical
overlap between the two companies. In North America, which is the leading market for both Unilever
and Kraft, Unilever mainly sells tea and ice creams while Kraft has a strong portfolio of sauces,
coffee, dairy, processed meats and ready meals. So the solution for Unilever could be to accelerate
margin delivery in order to prove it does not need Kraft's expertise. The group already has three
savings programmes – namely ZBB, Connected 4 Growth and net revenue management with pricing
initiatives – that aim to deliver EUR1bn in savings (net of restructuring charges) by 2018,
underpinning the guidance for 40-80bps EBIT margin improvement in the medium term.
Unilever could now allow more savings to fall through to the bottom line. It has already started to
head into this direction by revising its 2017 guidance upwards in a statement delivered on 22nd
February. It now targets EBIT margin improvement of 80bps vs +40bps.
CFO Mr Pitkethly may also push for deeper cuts. The savings generated by Unilever only account for
1.9% of its sales while Danone, General Mills or Kellogg have announced savings programmes that
respectively represent 4.5%, 4.2% or 8.7% of their sales. This strengthens our view the company can
exceed its objective of EUR1bn in savings by 2018.
28.1%
17.6% 16.9%15.3% 15.3%
13.8%
ReckittBenckiser
L'Oréal Henkel Nestlé Unilever Danone
Unilever
7
With additional cost savings and more reinvestment, Unilever could accelerate the EBIT margin
improvement to 80bps over the 2017-2020 period. One thing is sure: it will be of utmost importance
that the group gives a formal objective. The market did not react very positively to the upgrade to
mid-term guidance at the end of November because it was unofficial. The official guidance remained
for “steady improvement in margin”. Such a measure would imply an average EPS accretion of 4%
over the next four years (2017-2020 period) and a Fair Value of EUR45.8, 2% below yesterday’s share
price.
Fig. 3: EPS accretion in the event of a margin upgrade
EURm Our current estimate Our estimate if revision in guidance
2017e
Sales 55 580 55 580
EBIT 8 929 8 929
EBIT margin 16.1% 16.1%
Increase in bps 80 80
Financial result -530 -530
Associates 188 188
Tax -2220 -2220
Minority interest -400 -400
Net profit _ group share 5 967 5 967
EPS 2.09 2.09
Upward revision 0.0%
2018e
Sales 57 884 57 884
EBIT 9 568 9 782
EBIT margin 16.5% 16.9%
Increase in bps 40 80
Financial result -495 -495
Associates 195 195
Tax -2397 -2452
Minority interest -420 -420
Net profit _ group share 6 451 6 610
EPS 2.26 2.32
Upward revision 2.5%
2019e
Sales 60 657 60 657
EBIT 10 317 10 736
EBIT margin 17.0% 17.7%
Increase in bps 50 80
Financial result -460 -460
Associates 202 202
Tax -2602 -2711
Minority interest -434 -434
Net profit _ group share 7 023 7 333
EPS 2.46 2.57
Unilever
8
Upward revision 4.5%
2020e
Sales 64 431 64 431
EBIT 11 042 11 920
EBIT margin 17.1% 18.5%
Increase in bps 10 80
Financial result -430 -430
Associates 205 205
Tax -2870 -3100
Minority interest -450 -450
Net profit _ group share 7 497 8 145
EPS 2.63 2.85
Upward revision 8.6%
Source: Company Data; Bryan, Garnier & Co ests.
Unilever
9
4. Increasing cash returns to shareholders
The group is in a very healthy financial situation. This left it exposed to Kraft-Heinz, which planned
to raise debt against its strong balance sheet to help fund its purchase. We expect Unilever to have a
ratio of net debt/EBITDA of 1.0x in 2017 (1.3x in 2016).
Fig. 4: Financial structure
Source: Company Data; Bryan, Garnier & Co ests.
The group could increase its net debt/EBITDA ratio up to two and a half times in order to deter
further proposals but also to return cash to shareholders. It would have EUR15.9bn to spend,
assuming a 2017 EBITDA of EUR10.5bn.
Fig. 5: Firepower
EURm 2017e 2018e 2019e
Net debt/EBITDA ratio 1.0x 0.7x 0.5x
2.0x
Total net debt 21,048 22,474 24,146
Surplus of available cash 10,628 14,429 18,680
2.5x
Total net debt 26,310 28,092 30,183
Surplus of available cash 15,890 20,047 24,717
3.0x
Total net debt 31,573 33,710 36,219
Surplus of available cash 21,153 25,665 30,753
Source: Unilever, Bryan, Garnier & Co
7 355 8 456 9 900 11 505 12 614 10 420 8 045 5 466
0.91.0
1.2 1.2
1.3
1.0
0.7
0.5
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
0
2 000
4 000
6 000
8 000
10 000
12 000
14 000
2012 2013 2014 2015 2016 2017e 2018e 2019e
Net debt Net debt/EBITDA
Unilever
10
The last buyback that was carried out by Unilever took place in 2007 as Mr Polman used to view the
process as meaningless. He may now consider it as the least bad alternative. It is unlikely that Unilever
would spend its total firepower of EUR15.9bn on buying back shares. Assuming it uses 50%, this
would increase our 2017e EPS by 8.1% and would point to a Fair Value of EUR47.5, 2% above
yesterday’s share price.
Fig. 6: Simulation of a share buyback programme in 2017
% of the EUR15,900m cash which is used 30% 50% 80%
Amount of the EUR15,900m cash which is used 4 770 7 950 12 720
Number of repurchased shares (in millions) 102 170 272
New diluted EPS 2.20 2.26 2.35
Old diluted EPS 2.09 2.09 2.09
Accretive impact +5.2% +8.1% +12.4%
Source: Unilever, Bryan, Garnier & Co
Unilever is already one of the best in class companies in terms of returns to shareholders through
dividends. Its dividend has increased by an average of 8% per annum over the last 35 years. The
dividend pay-out ratio of 68% in 2016 compares favourably with an industry average of 55%. That’s
why we think the group should favour a buyback.
Fig. 7: Pay-out ratio
Source: Company Data; Bryan, Garnier & Co ests
34%
51%
51%
55%
55%
68%
68%
Henkel
Reckitt Benckiser
L'Oréal
Average
Danone
Nestlé
Unilever
Unilever
11
5. Disposal of the spreads business in developed countries
Before the Kraft-Heinz offer, Unilever was trading on a 2017e P/E multiple of 20.7x vs an average of
22.9x for HPC peers and 21.6x for food peers. This raised questions as to whether the market may
not have recognised the value of each business and whether management should consider a break-up
of Food and HPC to unlock value. We think it is highly unlikely that Unilever would agree to such a
radical step. The two businesses are intrinsically integrated from a cost standpoint and provide each
other critical mass in emerging countries, which account for 57% of total sales. Even if we do not
believe in such a scenario, we have calculated that it would lead to a Fair Value of EUR48, assuming
pure trading multiples, and a Fair Value of EUR61 assuming take-out multiples (premium of 25%).
Fig. 8: SOTP with pure trading multiples
2017e EBIT * Trading multiple = EV
Food 3,474 16.5 57,321
HPC 5,296 17.1 90,562
EV _ Food 57,321
EV _ HPC 90,562
Total EV 147,883
-Net debt -10,420
Total equity 137,463
Number of shares 2,854
Fair Value 48
Source of all tabs: Unilever, Bryan, Garnier & Co
Fig. 9: SOTP with take-out multiples
2017e EBIT * Trading multiple = EV
Food 3,474 20.6 71,564
HPC 5,296 21.4 113,334
EV - Food 74,517
EV _ HPC 117,730
Total EV 184,899
-Net debt -10 420
Total equity 174,479
Number of shares 2854
Fair Value 61
Source of all tabs: Unilever, Bryan, Garnier & Co
Unilever
12
Whereas we do not believe in the break-up of the food and the HPC businesses, we are not ruling out
a disposal of the spread business in developed countries. This activity has been declining constantly
for many years due to a change in consumer tastes to prioritise natural foods over those presented as
healthy. Unlike butter, spread comes from a factory. The decline in bread consumption and the
substantial reduction in the price of butter between 2014 and 2015 constituted aggravated factors.
The group has taken numerous initiatives to restore the performance of this activity. It has innovated
by creating mixtures (butter + margarine), products used for cooking (a growing segment), or by
changing the texture (liquid margarine). It has also changed the marketing content by emphasising the
naturalness of its products and trying to reactivate the pro-active brand, which aims to reduce
cholesterol. So far, all these initiatives have proved to be unsuccessful.
However, the group has always been reluctant to dispose of the spreads business, which is an
historical activity. After all, it was formed by the merger of the English soap and the Dutch spread
activities. It has also been motivated by business's high profitability (20% EBIT margin vs 15.3% for
the group) and cash flow generation. Another reason was that Unilever set up a separate unit for the
European and US activities in July 2015, named the Backing, Cooking and Spreads (BCS) unit and,
consequently, the company has been more than able to offset the operating impact of volume losses
with savings.
By applying an EV/EBIT multiple of 13.1x (20% discount relative to the average multiples for food
companies as the activity is in structural decline), we derive an enterprise value of EUR6bn. Operating
deleverage is likely to be limited since the BCS unit has its own distribution network and central
functions. We calculate a dilutive impact of 6% on EPS. This only works out to 1% if the proceeds
are used to repurchase shares. We think that, despite the dilution, the disposal would be well received
by the market as it would mechanically increase the group’s organic sales growth by 30bps and would
increase management's attention on other divisions.
Unilever
13
6. Tactical acquisitions on the agenda
The group has made many acquisitions in the eight years since Mr Polman became CEO. Most of
them were in HPC (eight out of the past 10) in order to reduce exposure to the low growth food
segments. Unilever's Home Care and Personal Care divisions registered growth twice as high as that
of Foods/Refreshments. The group’s (informal) objective is to generate 70% of sales in Personal Care
and Home Care products by 2020. In 2016, they generated 57% of the group’s sales (49% in 2010).
Fig. 10: Composition of the Unilever portfolio between Food and HPC
Fig. 11: Growth in the Food and HPC divisions
Source: Company Data; Bryan, Garnier & Co ests.
Within the personal care category, prestige brands remain Unilever’s preferred target. The group is
aiming to generate EUR1bn in sales in the segment by 2020 versus EUR400m (including Nexxus)
currently. As a comparison, L’Oréal generates more than EUR4bn in prestige brands (in its Luxury
and Active Cosmetics division). The aim is to gradually correct its overexposure to the mass market
segment whose growth rate is 3% versus 6% for prestige brands, and whose margins are inferior.
The group was particularly active in personal care in 2015, acquiring the Murad, Dermalogica, Kate
Somerville and REN brands in prestige skincare. In 2016, it acquired Dollar Shave Club, which is
specialised in a direct to consumer e-commerce sales model for shaving products and Living Proof in
premium hair care. Home Care was not neglected. Last year, Unilever bought Blue Air, which is an air
purification system and Seventh Generation, which introduced natural products into the US. We
calculate that all the bolt-on deals over the 2015-2016 period added just 2.2% to overall revenues.
51% 49% 47% 46% 44% 43% 43%
49% 51% 53% 54% 56% 57% 57%
2010 2011 2012 2013 2014 2015 2016
Food & Refreshment HPC
4.1%
0.7%
1.6%
3.5%2.8% 2.5%
10.2%
7.7%
4.7% 5.0%4.6%
6.4%
2012 2013 2014 2015 2016 5-year average
Food & Refreshment HPC
Unilever
14
Fig. 12: Acquisitions in 2015 and 2016
Date Company Business Target Sales (EURm) % of sales
2016 Living Proof Personal Care Premium hair care 46 0.1%
2016 Seventh Generation Home Care Natural house cleaning 184 0.3%
2016 Dollar Shave Club Personal Care Shaving products sold online 184 0.3%
2016 Blueair Home Care Air purification 98 0.2%
2015 GROM Refreshment Premium ice cream 50 0.1%
2015 Murad Personal Care Clinical skincare 106 0.2%
2015 Dermatologica Personal Care Skincare for professionals 221 0.4%
2015 Kate Somerville Personal Care Prestige skincare 50 0.1%
2015 REN Personal Care Skincare 50 0.1%
2015 Camay & Zest brands Personal Care Skin cleansing 207 0.4%
TOTAL 2.2%
Source: Company Data; Bryan, Garnier & Co ests.
Faced with the threat from Kraft-Heinz, Unilever could be more aggressive in acquisitions. And it has
the resources to do so. Assuming a net debt/EBITDA ratio of 2.5 and a 2017 EBITDA of
EU10.5bn, the group would have EUR15.9bn to spend.
Sizeable acquisitions could be possible in higher growth HPC, with targets such as Estée Lauder,
Colgate Palmolive or Beiersdorf. We rule out Estée Lauder (40% owned by the Lauder family) and
Beiersdorf (51% owned by Maxingvest Group) due to family ownership.
Colgate has been mooted as a target numerous times in recent years. The acquisition of the latter
would help Unilever to achieve its goal of generating 70% of sales in personal care and home care
products by 2020, thereby accelerating its transition from a food player to an HPC company. Its HPC
sales would increase by 500bps to 63% of total sales.
Fig. 13: Composition of the Unilever portfolio, 2017e
Fig. 14: Composition of the Unilever portfolio in the event of the acquisition of Colgate, 2017e
Source: Unilever, Colgate, Bryan, Garnier & Co
We consider this acquisition extremely difficult to pull off from a financial perspective. Assuming a
35% premium to the current share price, it would cost the company USD96 per share or USD87bn
Foods23%
Refreshment18%
Home Care20%
Personal Care39%
Total food:42%
Total HPC:58%
Foods19%
Refreshment15%
Pet nutrition3%
Personal care44%
Home Care19%
Total HPC:63%
Total food:37%
Unilever
15
(EUR80bn). Net debt would thus reach a very high level of 6.2x, even taking into account synergies
equivalent to 5% of sales. For the net debt/EBITDA ratio to fall to a more reasonable level of 2.7x,
the group would have to issue shares on a one for two basis at a price of EUR37.4 (a 20% discount to
current level).
Fig. 15: Impact of the acquisition of Colgate on the net debt/EBITDA ratio, 2017e
EURm 100% debt 1 for 2 right s issue
Net debt _ Unilever 10 408 10 408
Net debt _ Colgate 4 812 4 812
Debt issued for Colgate 80 000 26 836
Total net debt 95 220 42 056
Equity issue 0 53 164
EBITDA _ Unilever 10 374 10 374
EBITDA _ Colgate incl.synergies 4 884 4 884
Total EBITDA 15 377 15 377
Net debt/EBITDA 6.2x 2.7x
Source: Companies, Bryan, Garnier & Co
This acquisition would also be highly complex due to anti-trust reasons. A disposal of a portion of the
two companies would be required. We consider it very unlikely that Unilever will launch such a
transaction while a number of efforts need to be made internally.
An acquisition of a smaller company such as Edgewell seems far more likely. Financially, this is
possible. If Unilever offered a premium of 30%, this would “only” cost EUR5bn while the group has
firepower of EUR15.9bn assuming a net debt/EBITDA ratio of 2.5x. But it would add 4% to the
group’s sales. There is a strong strategic rationale behind acquiring Edgewell. The group is
underexposed to emerging countries while they account for 57% of Unilever’s sales. The Anglo-
Dutch company could use its network to expand the business. This would be particularly beneficial,
especially for the shaving business (60% of Edgewell’s sales) as 40% of this market is in EMs.
Unilever
16
7. Conclusion
We think the company will choose the most cautious options which are accelerating margin
improvement and increasing returns to shareholders (buyback). Why? Two reasons: 1/ there is no
need for Unilever to change its entire strategy simply because Kraft-Heinz made an attempt and 2/
Unilever is not an underperformer with a TSR of 194% over the past eight years vs 137% for the
Stoxx Europe 600. The ideas of splitting food and HPC, disposing of the entire food business or
undertaking major M&A moves seem overly aggressive to us. However, we are not ruling out the
prospect of the group deciding to sell its BCS unit.
1) Accelerating margin improvement
The value creation of a Kraft-Heinz bid for Unilever was due to come from the cost savings that
would have been generated by applying the cost savings culture of Kraft-Heinz to the Anglo-Dutch
company. So now the solution for Unilever could be to accelerate margin delivery in order to prove it
does not need Kraft's expertise. The group already has three savings programmes – namely ZBB,
Connected 4 Growth and net revenue management with pricing initiatives – that aim to deliver
EUR1bn in savings (net of restructuring charges) by 2018, underpinning MT guidance for a 40-80bps
EBIT margin improvement in coming years. Unilever could now allow more savings to fall through
to the bottom line. It has already started to head in this direction by revising upward its 2017 guidance
in a statement delivered on 22nd February. It now targets EBIT margin improvement of 80bps vs
+40bps. CFO Mr Pitkethly may also push for deeper cuts. The savings generated by Unilever only
account for 1.9% of its sales while Danone, General Mills or Kellogg have announced savings
programmes that respectively represent 4.5%, 4.2% or 8.7% of their sales. This strengthens our view
that the company could exceed its objective of EUR1bn savings by 2018. With additional cost savings
and more reinvestment, Unilever could accelerate EBIT margin improvement to 80bps over the 2017-
2020 period. One thing is sure: it will be of utmost importance that the group provides a formal
objective. The market did not react very positively to the upgrade to mid-term guidance at the end of
November because it was unofficial. The official guidance remained for “steady improvement in
margin”. Such a measure would imply an average EPS accretion of 4% over the next four years (2017-
2020 period) and a Fair Value of EUR45.8, 2% below yesterday’s share price.
2) Increasing returns to shareholders through buybacks
The group is in a very healthy financial situation. This has left it exposed to Kraft-Heinz, which
planned to raise debt against its strong balance sheet to help fund its purchase. We expect Unilever to
have a net debt/EBITDA ratio of 1.0x in 2017 (1.3x in 2016). The group could increase its net
debt/EBITDA ratio up to two and a half times in order to deter further proposals but also to return
cash to shareholders. It would have EUR15.9bn to spend, assuming 2017 EBITDA of EUR10.5bn.
The last buyback that was carried out by Unilever took place in 2007 as Mr Polman used to view the
process as meaningless. He may now consider it as the least bad alternative. It is unlikely that Unilever
would spend its total firepower of EUR15.9bn on buying back shares. Assuming it uses 50%, this
would increase our 2017e EPS by 8.1% and would point to a Fair Value of EUR47.5, 2% above
yesterday’s share price.
Unilever
17
If Unilever choses to both accelerate margin improvement (+80bps over the 2017-2020 period) and
increase returns to shareholders through buybacks, this would increase our FV from EUR44 to
EUR49.5, implying upside potential of only 6%. This means the positive news we expect from the
group is already partly factored into the share price while any disappointment could have a very
detrimental impact for the share performance, especially Q1 2017 should be very soft. Like its peers,
Unilever is expected to be impacted by the leap year and the late timing of Easter. These should have
a negative technical effect of -100bps and -50bps. The slowdown in Brazil, the demonetisation in
India, political uncertainty and delays in tax returns in the US should also be penalising. Our estimate
calls for 1% organic sales growth in Q1 vs +3.5% in 2017.
What are the implications for the sector?
The Danone share price rose 3% on speculation. A takeover bid could be possible due to
the shareholding structure. The stake of the historical friendly shareholders (Eurazeo, CDC,
Sofina, Predica) was significantly reduced while the reference shareholder has become MFS
(Massachusetts Financial Services). In addition, Anglo-US companies now account for 58%
of the capital held by institutional investors. If this is theoretically possible, it has to be
remembered that Danone has never been the target of a takeover bid. The offer from
PepsiCo in 2005 was just a rumour. Furthermore, note that Danone announced the
acquisition of the US company WhiteWave in July 2016, which demonstrates a willingness to
grow.
Will Nestlé need to grow? A combination of Kraft/Unilever would have created the second
consumer group in the world with market capitalisation of USD229bn vs Nestlé at
USD231bn. At the full year results release, the Swiss company indicated that it does not
want to pursue big M&A deals at the moment. It could now be forced to rush things. To
grow, it might be tempted to sell L'Oreal shares (it owns 23%) to the French cosmetics
group. We do not think the disposal will exceed 10% because L’Oréal is not allowed to
cancel more than 10% of its shares over a 24-month period. This would imply a 13%
accretive impact on L’Oréal. The market was not mistaken in immediately buying the share
on the announcement of Kraft's bid for Unilever. Note that Nestlé denied it would do so at
the release of its full year results before the Kraft bid on Unilever.
Unilever
18
Price Chart and Rating History
Unilever
Ratings
Date Ratings Price
10/06/16 NEUTRAL EUR40.95
14/11/11 end of coverage EUR99
03/05/11 NEUTRAL EUR22.39
17/09/09 BUY EUR19.03
06/08/09 No rating EUR19.8
11/02/09 SELL EUR16.445
Target Price
Date Target price
23/02/17 EUR44
27/01/17 EUR42
02/11/16 EUR44
10/06/16 EUR43
29.7
31.7
33.7
35.7
37.7
39.7
41.7
43.7
45.7
47.7
30/09/15 31/12/15 31/03/16 30/06/16 30/09/16 31/12/16
UNILEVER DR Fair Value Achat Neutre Vente
Unilever
19
Bryan Garnier stock rating system For the purposes of this Report, the Bryan Garnier stock rating system is defined as follows:
Stock rating
BUY Positive opinion for a stock where we expect a favourable performance in absolute terms over a period of 6 months from the publication of a
recommendation. This opinion is based not only on the FV (the potential upside based on valuation), but also takes into account a number of
elements that could include a SWOT analysis, momentum, technical aspects or the sector backdrop. Every subsequent published update on the stock
will feature an introduction outlining the key reasons behind the opinion.
NEUTRAL Opinion recommending not to trade in a stock short-term, neither as a BUYER or a SELLER, due to a specific set of factors. This view is intended to
be temporary. It may reflect different situations, but in particular those where a fair value shows no significant potential or where an upcoming binary
event constitutes a high-risk that is difficult to quantify. Every subsequent published update on the stock will feature an introduction outlining the key
reasons behind the opinion.
SELL Negative opinion for a stock where we expect an unfavourable performance in absolute terms over a period of 6 months from the publication of a
recommendation. This opinion is based not only on the FV (the potential downside based on valuation), but also takes into account a number of
elements that could include a SWOT analysis, momentum, technical aspects or the sector backdrop. Every subsequent published update on the stock
will feature an introduction outlining the key reasons behind the opinion.
Distribution of stock ratings
BUY ratings 48,5% NEUTRAL ratings 36,2% SELL ratings 15,3%
Research Disclosure Legend
1 Bryan Garnier shareholding in Issuer
Bryan Garnier & Co Limited or another company in its group (together, the “Bryan Garnier Group”) has a shareholding that, individually or combined, exceeds 5% of the paid up and issued share capital of a company that is the subject of this Report (the “Issuer”).
No
2 Issuer shareholding in Bryan Garnier
The Issuer has a shareholding that exceeds 5% of the paid up and issued share capital of one or more members of the Bryan Garnier Group.
No
3 Financial interest A member of the Bryan Garnier Group holds one or more financial interests in relation to the Issuer which are significant in relation to this report
No
4 Market maker or liquidity provider
A member of the Bryan Garnier Group is a market maker or liquidity provider in the securities of the Issuer or in any related derivatives.
No
5 Lead/co-lead manager In the past twelve months, a member of the Bryan Garnier Group has been lead manager or co-lead manager of one or more publicly disclosed offers of securities of the Issuer or in any related derivatives.
No
6 Investment banking agreement
A member of the Bryan Garnier Group is or has in the past twelve months been party to an agreement with the Issuer relating to the provision of investment banking services, or has in that period received payment or been promised payment in respect of such services.
No
7 Research agreement A member of the Bryan Garnier Group is party to an agreement with the Issuer relating to the production of this Report.
No
8 Analyst receipt or purchase of shares in Issuer
The investment analyst or another person involved in the preparation of this Report has received or purchased shares of the Issuer prior to a public offering of those shares.
No
9 Remuneration of analyst The remuneration of the investment analyst or other persons involved in the preparation of this Report is tied to investment banking transactions performed by the Bryan Garnier Group.
No
10 Corporate finance client In the past twelve months a member of the Bryan Garnier Group has been remunerated for providing corporate finance services to the issuer or may expect to receive or intend to seek remuneration for corporate finance services from the Issuer in the next six months.
No
11 Analyst has short position The investment analyst or another person involved in the preparation of this Report has a short position in the securities or derivatives of the Issuer.
No
12 Analyst has long position The investment analyst or another person involved in the preparation of this Report has a long position in the securities or derivatives of the Issuer.
No
13 Bryan Garnier executive is an officer
A partner, director, officer, employee or agent of the Bryan Garnier Group, or a member of such person’s household, is a partner, director, officer or an employee of, or adviser to, the Issuer or one of its parents or subsidiaries. The name of such person or persons is disclosed above.
No
14 Analyst disclosure The analyst hereby certifies that neither the views expressed in the research, nor the timing of the publication of the research has been influenced by any knowledge of clients positions and that the views expressed in the report accurately reflect his/her personal views about the investment and issuer to which the report relates and that no part of his/her remuneration was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in the report.
Yes
15 Other disclosures Other specific disclosures: Report sent to Issuer to verify factual accuracy (with the recommendation/rating, price target/spread and summary of conclusions removed).
No
Summary of Investment Research Conflict Management Policy is available www.bryangarnier.com
London
Beaufort House
15 St. Botolph Street
London EC3A 7BB
Tel: +44 (0) 207 332 2500
Fax: +44 (0) 207 332 2559
Authorised and regulated by the Financial
Conduct Authority (FCA)
Paris
26 Avenue des Champs Elysées
75008 Paris
Tel: +33 (0) 1 56 68 75 00
Fax: +33 (0) 1 56 68 75 01
Regulated by the
Financial Conduct Authority (FCA) and
the Autorité de Contrôle prudential et de
resolution (ACPR)
New York
750 Lexington Avenue
New York, NY 10022
Tel: +1 (0) 212 337 7000
Fax: +1 (0) 212 337 7002
FINRA and SIPC member
Munich
Widenmayerstrasse 29
80538 Munich
Germany
+49 89 2422 62 11
Important information
This document is classified under the FCA Handbook as being investment research (independent research). Bryan Garnier & Co Limited has in place the measures and arrangements required for investment research as set out in the FCA’s Conduct of Business Sourcebook. This report is prepared by Bryan Garnier & Co Limited, registered in England Number 03034095 and its MIFID branch registered in France Number 452 605 512. Bryan Garnier & Co Limited is authorised and regulated by the Financial Conduct Authority (Firm Reference Number 178733) and is a member of the London Stock Exchange. Registered address: Beaufort House 15 St. Botolph Street, London EC3A 7BB, United Kingdom This Report is provided for information purposes only and does not constitute an offer, or a solicitation of an offer, to buy or sell relevant securities, including securities mentioned in this Report and options, warrants or rights to or interests in any such securities. This Report is for general circulation to clients of the Firm and as such is not, and should not be construed as, investment advice or a personal recommendation. No account is taken of the investment objectives, financial situation or particular needs of any person. The information and opinions contained in this Report have been compiled from and are based upon generally available information which the Firm believes to be reliable but the accuracy of which cannot be guaranteed. All components and estimates given are statements of the Firm, or an associated company’s, opinion only and no express representation or warranty is given or should be implied from such statements. All opinions expressed in this Report are subject to change without notice. To the fullest extent permitted by law neither the Firm nor any associated company accept any liability whatsoever for any direct or consequential loss arising from the use of this Report. Information may be available to the Firm and/or associated companies which are not reflected in this Report. The Firm or an associated company may have a consulting relationship with a company which is the subject of this Report. This Report may not be reproduced, distributed or published by you for any purpose except with the Firm’s prior written permission. The Firm reserves all rights in relation to this Report. Past performance information contained in this Report is not an indication of future performance. The information in this report has not been audited or verified by an independent party and should not be seen as an indication of returns which might be received by investors. Similarly, where projections, forecasts, targeted or illustrative returns or related statements or expressions of opinion are given (“Forward Looking Information”) they should not be regarded as a guarantee, prediction or definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. A number of factors, in addition to the risk factors stated in this Report, could cause actual results to differ materially from those in any Forward Looking Information. Disclosures specific to clients in the United Kingdom This Report has not been approved by Bryan Garnier & Co Limited for the purposes of section 21 of the Financial Services and Markets Act 2000 because it is being distributed in the United Kingdom only to persons who have been classified by Bryan Garnier & Co Limited as professional clients or eligible counterparties. Any recipient who is not such a person should return the Report to Bryan Garnier & Co Limited immediately and should not rely on it for any purposes whatsoever. Notice to US investors This research report (the “Report”) was prepared by Bryan Garnier & Co Limited for information purposes only. The Report is intended for distribution in the United States to “Major US Institutional Investors” as defined in SEC Rule 15a-6 and may not be furnished to any other person in the United States. Each Major US Institutional Investor which receives a copy of this Report by its acceptance hereof represents and agrees that it shall not distribute or provide this Report to any other person. Any US person that desires to effect transactions in any security discussed in this Report should call or write to our US affiliated broker, Bryan Garnier Securities, LLC. 750 Lexington Avenue, New York NY 10022. Telephone: 1-212-337-7000. This Report is based on information obtained from sources that Bryan Garnier & Co Limited believes to be reliable and, to the best of its knowledge, contains no misleading, untrue or false statements but which it has not independently verified. Neither Bryan Garnier & Co Limited and/or Bryan Garnier Securities LLC make no guarantee, representation or warranty as to its accuracy or completeness. Expressions of opinion herein are subject to change without notice. This Report is not an offer to buy or sell any security. Bryan Garnier Securities, LLC and/or its affiliate, Bryan Garnier & Co Limited may own more than 1% of the securities of the company(ies) which is (are) the subject matter of this Report, may act as a market maker in the securities of the company(ies) discussed herein, may manage or co-manage a public offering of securities for the subject company(ies), may sell such securities to or buy them from customers on a principal basis and may also perform or seek to perform investment banking services for the company(ies).
Bryan Garnier Securities, LLC and/or Bryan Garnier & Co Limited are unaware of any actual, material conflict of interest of the research analyst who prepared this Report and are
also not aware that the research analyst knew or had reason to know of any actual, material conflict of interest at the time this Report is distributed or made available..